LESCARDEN INC
10KSB, EX-27, 2000-08-28
PHARMACEUTICAL PREPARATIONS
Previous: LESCARDEN INC, 10KSB, 2000-08-28
Next: MFS SERIES TRUST IX /MA/, 485BPOS, 2000-08-28



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM LESCARDEN
INC'S MAY 31, 2000 FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAY-31-2000
<PERIOD-END>                               MAY-31-2000
<CASH>                                          43,449
<SECURITIES>                                         0
<RECEIVABLES>                                   71,532
<ALLOWANCES>                                         0
<INVENTORY>                                     99,880
<CURRENT-ASSETS>                               214,861
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 214,861
<CURRENT-LIABILITIES>                          213,213
<BONDS>                                              0
                                0
                                      1,840
<COMMON>                                        22,319
<OTHER-SE>                                    (22,511)
<TOTAL-LIABILITY-AND-EQUITY>                   214,861
<SALES>                                        346,633
<TOTAL-REVENUES>                               434,581
<CGS>                                          218,380
<TOTAL-COSTS>                                1,040,667
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (606,086)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (606,086)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (606,086)
<EPS-BASIC>                                    (.03)
<EPS-DILUTED>                                    (.03)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission